US pharmaceutical company MSD stops supply of vaccines to Russia

US pharmaceutical company MSD has reportedly stopped supplying vaccines to Russia, against chickenpox, measles, rubella and mumps, as reported on Monday, July 4.

MSD, a US pharmaceutical company has stopped its vaccine supply to Russia, including vaccines against chickenpox, measles, rubella and mumps, as reported by currenttime.

The company also also confirmed the information about the suspension of cooperation with Russia.

The production of MSD vaccines against chickenpox, rotavirus and human papilloma virus has been localised at its Forta site since 2019. The site now produces seasonal vaccines.

The company claimed that it is currently “doing its best” to supply vitally important drugs and vaccines which to Russia.

Russia’s Federal Service for Surveillance in Healthcare’s  press service said Russia has “sufficient domestic vaccines” to prevent chickenpox, measles, rubella and mumps.

According to Alexei Kuznetsov, an aide to the Russian Health Minister, the termination of supplies of MSD vaccines to the country will not adversely affect the availability of vaccination to Russians.

Over a thousand Western companies have reportedly already left Russia since the war with Ukraine began. with the country’s authorities promising to replace imported goods with domestic ones. 

One such example is that of IKEA who decided to “scale down its business” in Russia with employees set to be “optimised”, as reported on June 15.

Thank you for taking the time to read this article, do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories and remember, you can also follow us on Facebook and Instagram.